Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort-Reference-Cited by-同舟云学术

Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort

Published:2017-08-19 Issue:10 Volume:65 Page:1615-1623
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Palacios-Baena Zaira Raquel¹,Gutiérrez-Gutiérrez Belén¹,Calbo Esther²,Almirante Benito³,Viale Pierluigi⁴,Oliver Antonio⁵,Pintado Vicente⁶,Gasch Oriol⁷,Martínez-Martínez Luis⁸,Pitout Johann⁹,Akova Murat¹⁰,Peña Carmen¹¹,Molina Gil-Bermejo José¹,Hernández Alicia¹²,Venditti Mario¹³,Prim Nuria¹⁴,Bou German¹⁵,Tacconelli Evelina¹⁶,Tumbarello Mario¹⁷,Hamprecht Axel¹⁸,Giamarellou Helen¹⁹,Almela Manel²⁰,Pérez Federico²¹,Schwaber Mitchell J²²,Bermejo Joaquín²³,Lowman Warren²⁴,Hsueh Po-Ren²⁵,Paño-Pardo José Ramón²⁶,Torre-Cisneros Julián²⁷,Souli Maria²⁸,Bonomo Robert A²⁹,Carmeli Yehuda²²,Paterson David L³⁰,Pascual Álvaro¹,Rodríguez-Baño Jesús¹,Gálvez J,Falcone M,Russo A,Daikos G,Trecarichi E M,Losito A R,Gómez J,Iosifidis E,Roilides E,Karaiskos I,Doi Y,Tuon F F,Navarro F,Mirelis B,Martínez JA,de la Calle C,Morata L,San Juan R,Fernández-Ruiz M,Larrosa N,Puig M,Molina J,González V,Rucci V,Ruiz de Gopegui E,Marinescu C I,Fariñas M C,Cano M E,Gozalo M,Mora-Rillo M,Gómez-Zorrilla S,Tubau F,Pournaras S,Tsakris A,Zarkotou O,Azap Ö K,Antoniadou A,Poulakou G,Virmani D,Cano Á,Machuca I,Helvaci Ö,Sahin A O,Ruiz-Garbajosa P,Bartoletti M,Giannella M,Peter S,Badia C,Xercavins M,Fontanals D,Jové E,

Affiliation:

1. Unidad de Gestión Clínica de Enfermedades Infecciosas y Microbiología/Instituto de Biomedicina de Sevilla/Hospital Universitario Virgen Macarena/Universidad de Sevilla

2. Hospital Universitari Mútua de Terrassa, Universitat Internacional de Catalunya

3. Hospital Vall d’Hebrón, Barcelona, Spain

4. Teaching Hospital Policlinico S. Orsola Malpighi, Bologna, Italy

5. Hospital Universitario Son Espases, Mallorca

6. Hospital Ramón y Cajal, Madrid

7. Hospital Parc Taulí, Barcelona

8. Hospital Universitario M. de Valdecilla-IDIVAL, Santander, Spain

9. University of Calgary, Alberta, Canada

10. Hacettepe University School of Medicine, Ankara, Turkey

11. Hospital Bellvitge, Barcelona

12. Hospital Virgen de la Arrixaca, Murcia, Spain

13. Policlinico Umberto I, Rome, Italy

14. Hospital de la Santa Creu i Sant Pau, Barcelona

15. Complejo Hospitalario Universitario A Coruña, Spain

16. Tübingen University Hospital and DZIF Partner Center, Germany

17. Catholic University of the Sacred Heart, Rome, Italy

18. Institut für Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Köln, Cologne, Germany

19. Hygeia General Hospital, Athens, Greece

20. Hospital Clinic, Barcelona, Spain

21. Louis Stokes Cleveland Veteran Affairs Medical Center, Case Western Reserve University, Ohio

22. Tel Aviv Sourasky Medical Center, National Center for Infection Control, Israel Ministry of Health, and Sackler Faculty of Medicine, Tel Aviv University

23. Hospital Español, Rosario, Argentina

24. Wits Donald Gordon Medical Centre, Johannesburg, South Africa

25. National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei

26. Hospital La Paz, Madrid

27. Maimonides Biomedical Research Institute of Córdoba, Unidades de Gestión Clínica de Enfermedades Infecciosas y Microbiología, Reina Sofia University Hospital and University of Córdoba, Spain

28. National and Kapodistrian University of Athens, School of Medicine, University General Hospital Attikon, Greece

29. Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center and Departments of Medicine, Pharmacology, Biochemistry, and Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Ohio

30. University of Queensland Centre for Clinical Research, Herston, Brisbane, Australia

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/65/10/1615/24266850/cix606.pdf

Reference27 articles.

1. Extended-spectrum beta-lactamases: a clinical update;Paterson;Clin Microbiol Rev,2005

2. Clinical significance of extended-spectrum beta-lactamases;Rodríguez-Baño;Expert Rev Anti Infect Ther,2008

3. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern;Pitout;Lancet Infect Dis,2008

4. The global epidemiology of carbapenemase-producing Enterobacteriaceae;Van Duin;Virulence,2016

5. β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts;Rodríguez-Baño;Clin Infect Dis,2012

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort study;Microbiology Spectrum;2024-07-02

2. Real-World Experience of Ceftobiprole for Community- and Hospital-Acquired Pneumonia from a Stewardship Perspective;Microorganisms;2024-04-03

3. A randomized, controlled trial of prulifloxacin as conversion therapy after intravenous carbapenem in the treatment of acute pyelonephritis caused by third generation cephalosporin resistant pathogens: A pilot study;Clinical and Translational Science;2023-10-28

4. Efficacy of Carbapenems Compared With Noncarbapenem Broad-Spectrum Beta-Lactam Antibiotics as Initial Antibiotic Therapy Against Sepsis: A Nationwide Observational Study*;Critical Care Medicine;2023-05-26

5. Antibiotic stewardship in the ICU: time to shift into overdrive;Annals of Intensive Care;2023-05-06